4//SEC Filing
Oxtoby Andrew 4
Accession 0001209191-23-014787
CIK 0001435049other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 5:00 PM ET
Size
8.3 KB
Accession
0001209191-23-014787
Insider Transaction Report
Form 4
Oxtoby Andrew
Chief Commercial Officer
Transactions
- Award
Restricted Stock (RSU)(Common Stock)
2023-02-28+40,000→ 40,000 total→ Common Stock (40,000 underlying) - Award
Stock Option (right to buy)
2023-02-28+160,000→ 160,000 totalExercise: $21.82Exp: 2033-02-27→ Common Stock (160,000 underlying)
Footnotes (3)
- [F1]The stock option vests as to 25% of the total shares on February 28, 2024, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F2]Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
- [F3]The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on February 28, 2024, until fully vested subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Documents
Issuer
CHINOOK THERAPEUTICS, INC.
CIK 0001435049
Entity typeother
Related Parties
1- filerCIK 0001765473
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 5:00 PM ET
- Size
- 8.3 KB